Development of Macrocyclic Peptidomimetics Containing Constrained alpha , alpha-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors.
Merlino, F., Zhou, Y., Cai, M., Carotenuto, A., Yousif, A.M., Brancaccio, D., Di Maro, S., Zappavigna, S., Limatola, A., Novellino, E., Grieco, P., Hruby, V.J.(2018) J Med Chem 61: 4263-4269
- PubMed: 29660981
- DOI: https://doi.org/10.1021/acs.jmedchem.8b00488
- Primary Citation of Related Structures:
6FCE - PubMed Abstract:
We report the development of macrocyclic melanocortin derivatives of MT-II and SHU-9119, achieved by modifying the cycle dimension and incorporating constrained amino acids in ring-closing. This study culminated in the discovery of novel agonists/antagonists with an unprecedented activity profile by adding pieces to the puzzle of the melanocortin receptor selectivity. Finally, the resulting 19- and 20-membered rings represent a suitable frame for the design of further therapeutic ligands as selective modulators of the melanocortin system.
Organizational Affiliation:
Department of Pharmacy , University of Naples "Federico II" , Via D. Montesano 49 , 80131 Naples , Italy.